2020
DOI: 10.3390/biom10111542
|View full text |Cite
|
Sign up to set email alerts
|

Generation and Application of the Zebrafish heg1 Mutant as a Cardiovascular Disease Model

Abstract: Cardiovascular disease (CVD) is the leading cause of global mortality, which has caused a huge burden on the quality of human life. Therefore, experimental animal models of CVD have become essential tools for analyzing the pathogenesis, developing drug screening, and testing potential therapeutic strategies. In recent decades, zebrafish has entered the field of CVD as an important model organism. HEG1, a heart development protein with EGF like domains 1, plays important roles in the development of vertebrate c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
19
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(21 citation statements)
references
References 52 publications
2
19
0
Order By: Relevance
“…The heg1 CRISPR zebrafish mutant developed severe cardiovascular malformations, including an abnormal heart rate, atrial ventricular enlargement, venous thrombosis, and slow blood flow. All these symptoms are similar to those associated with human heart failure and thrombosis ( Lu SX et al, 2020 ). Thus, the zebrafish heg1 CRISPR mutant has potential to serve as an animal model for analyzing the pathogenesis of cardiovascular diseases, and screening and testing new drugs and their potential therapeutic targets.…”
Section: Wide Use Of Crispr/cas In Clinical and Preclinical Researcsupporting
confidence: 62%
See 1 more Smart Citation
“…The heg1 CRISPR zebrafish mutant developed severe cardiovascular malformations, including an abnormal heart rate, atrial ventricular enlargement, venous thrombosis, and slow blood flow. All these symptoms are similar to those associated with human heart failure and thrombosis ( Lu SX et al, 2020 ). Thus, the zebrafish heg1 CRISPR mutant has potential to serve as an animal model for analyzing the pathogenesis of cardiovascular diseases, and screening and testing new drugs and their potential therapeutic targets.…”
Section: Wide Use Of Crispr/cas In Clinical and Preclinical Researcsupporting
confidence: 62%
“…Cardiovascular disease is the leading cause of global death and threatens millions of people in their daily lives. Recently, Lu SX et al (2020) knocked out heg1 , a gene encoding a heart development protein with epidermal growth factor (EGF) like domains 1, in zebrafish. The heg1 CRISPR zebrafish mutant developed severe cardiovascular malformations, including an abnormal heart rate, atrial ventricular enlargement, venous thrombosis, and slow blood flow.…”
Section: Wide Use Of Crispr/cas In Clinical and Preclinical Researcmentioning
confidence: 99%
“…Embryonic zebrafish heg1 mutants show signs of severe HF ( Mably et al, 2003 ). heg1 knockout zebrafish generated with CRISPR-Cas9 show atrial and ventricular enlargement, slow heart rate and blood flow, and pericardial edema ( Lu et al, 2020 ). The authors used this DCM model for drug screening.…”
Section: Genetic Heart Failure Modelsmentioning
confidence: 99%
“…Counting was performed using a mechanical counter and stopwatch. The heart rate was expressed as beats per minute (bpm) [ 23 , 24 ].…”
Section: Methodsmentioning
confidence: 99%